Perrigo announces launch of AB-rated generic version of Topicort Topical Spray

Perrigo announced the launch of an AB-rated generic version of Topicort Topical Spray 0.25%. Topicort Topical Spray is indicated for the treatment of plaque psoriasis in patients 18 years of age or older. Annual market sales for the twelve months ending October 2018 were approximately $18M as measured by IQVIA.
https://thefly.com/landingPageNews.php?id=2834543